Drug firm ups swine flu vaccine production

GlaxoSmithKline today said its was in discussion with more than 50 countries about its swine flu vaccine as it announced contracts for 195 million doses worldwide were in place.

The drug firm said it expected further "significant orders" of the H1N1 vaccine and said that shipments of the medicine were expected in the second half of this year and early 2010.